RB
Rinji Borah
About Rinji Borah
Data last updated:
Rinji Borah has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Parantaa Drugs Private Limited and Nova Parantaa Drugs Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Parantaa Drugs Private Limited at ₹2.54 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parantaa Drugs Private Limited U85110AS2021PTC020971 | Director | 28 Jun 2021 | 2021 | ₹2.54 Cr (FY 2025) | Active |
| Nova Parantaa Drugs Private Limited U46497AS2026PTC029896 | Director | 13 Feb 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rinji Borah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rinji Borah
Rinji Borah has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Parantaa Drugs Private Limited and Nova Parantaa Drugs Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Parantaa Drugs Private Limited at ₹2.54 Cr (FY 2025).
Rinji Borah is associated with 2 companies as Director, including Parantaa Drugs Private Limited (₹2.54 Cr), Nova Parantaa Drugs Private Limited.
Rinji Borah has expertise in General Business.
Rinji Borah has 5 years in corporate governance.
By reported revenue, the largest current company of Rinji Borah is Parantaa Drugs Private Limited, with revenue of ₹2.54 Cr (FY 2025).
Rinji Borah currently holds positions at 2 companies: Parantaa Drugs Private Limited (₹2.54 Cr), Nova Parantaa Drugs Private Limited.